Mar 15 |
Mesa Labs Releases Second Annual Responsible Business Program Brochure
|
Mar 8 |
Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Could Be 39% Below Their Intrinsic Value Estimate
|
Feb 19 |
Mesa Laboratories (MLAB) Impacted by Slowdown in Pharmaceutical And Biotech Spending
|
Feb 8 |
Results: Mesa Laboratories, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
|
Feb 5 |
Mesa Labs (MLAB) Lags Q3 Earnings and Revenue Estimates
|
Feb 5 |
Mesa Laboratories Inc (MLAB) Faces Revenue Dip Amidst Strategic Acquisitions
|
Feb 5 |
Mesa Laboratories Non-GAAP EPS of $2.02 beats by $0.32, revenue of $53.47M misses by $1.13M
|
Feb 5 |
Mesa Labs Announces Third Quarter Results
|
Feb 5 |
Earnings Scheduled For February 5, 2024
|
Jan 8 |
Mesa Laboratories Appoints Mark Capone to its Board of Directors
|